Skip to main content
logo
Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
23.70
+1.84 (8.42%)
Nov 6, 2026, 4:00 PM EST - Market closed

Damora Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-291.68-209.84-21.44-38.35-61.62-51.75
Depreciation & Amortization
0.350.030.180.830.490.44
Loss (Gain) From Sale of Assets
-0.75---0.06--
Asset Writedown & Restructuring Costs
174.31174.31----
Loss (Gain) From Sale of Investments
-0.29-0.07-0.430.641.07
Stock-Based Compensation
17.31.043.335.435.574.48
Other Operating Activities
9.369.371.90.050.060.08
Change in Accounts Payable
10.5117.27-1.33-1.651.82-1.32
Change in Other Net Operating Assets
21.761.09-1.34-2.7210.12-5.3
Operating Cash Flow
-59.13-6.73-18.62-36.91-42.93-52.31
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-----0.2-0.22
Sale of Property, Plant & Equipment
---0.08--
Cash Acquisitions
-17.37-17.37----
Investment in Securities
-179.5-11.6522.2512.58-47.83
Investing Cash Flow
-196.13-17.3711.6522.3312.38-48.05

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
352.250.03-3.080.71-
Other Financing Activities
-21.67---0.2-0.2-
Financing Cash Flow
597.39266.84-2.880.51-

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.080.71-0.320.380.26-0.92
Net Cash Flow
342.05243.45-7.29-11.32-29.78-101.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-59.13-6.73-18.62-36.91-43.13-52.53
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.49-4.93-16.09-34.73-42.43-51.99
Levered Free Cash Flow
-18.55-3.05-10.55-21.45-19.68-33.19
Unlevered Free Cash Flow
-18.55-3.05-10.55-21.45-19.68-33.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
0.010.01----
Change in Working Capital
32.2718.36-2.67-4.3711.94-6.62
SEC Filings: 10-K · 10-Q